Moleculin Announces Corporate Rebranding and Launch of New Website

Company reiterates commitment to solving some of the toughest challenges in highly resistant cancers and viruses and developing better treatments that can make a real impact in people’s lives HOUSTON, April 14, 2022 /PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or…

Leave a Reply

Your email address will not be published.